{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:45:44Z","timestamp":1781538344055,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015213","name":"The University of Texas Medical Branch at Galveston Sealy Institute for Vaccine Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015213","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2025.126758","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:37:32Z","timestamp":1737520652000},"page":"126758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Real-world evidence of yellow Fever vaccination data-driven study"],"prefix":"10.1016","volume":"48","author":[{"given":"Madison G.","family":"Farnsworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Khanipov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostiantyn","family":"Botnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.T.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Golovko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126758_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41541-022-00552-3","article-title":"Yellow fever resurgence: an avoidable crisis?","volume":"7","author":"Lindsey","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.126758_bb0015","doi-asserted-by":"crossref","DOI":"10.31744\/einstein_journal\/2020RC5041","article-title":"Serious adverse event: late neurotropic disease associated with yellow fever vaccine","volume":"18","author":"de Oliveira","year":"2020","journal-title":"Einstein"},{"key":"10.1016\/j.vaccine.2025.126758_bb0020","series-title":"Yellow Fever. StatPearls [internet]","author":"Simon","year":"2023"},{"key":"10.1016\/j.vaccine.2025.126758_bb0025","first-page":"372","article-title":"Yellow Fever: origin, epidemiology","volume":"10","author":"Gianchecchi","year":"2022","journal-title":"Preventive Strategies Future Prospects Vaccines"},{"key":"10.1016\/j.vaccine.2025.126758_bb0030","series-title":"Chapter 64 - Yellow Fever Vaccine. In: Plotkin\u2019s Vaccines","first-page":"1251","author":"Staples","year":"2023"},{"key":"10.1016\/j.vaccine.2025.126758_bb0040","author":"Yellow Fever"},{"key":"10.1016\/j.vaccine.2025.126758_bb0050","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/trstmh\/tru092","article-title":"The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases","volume":"108","author":"Johansson","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126758_bb0055","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports\u202f: Morbidity and mortality weekly report","volume":"59","author":"Staples","year":"2010","journal-title":"Recommendations and reports"},{"key":"10.1016\/j.vaccine.2025.126758_bb0060","series-title":"CDC yellow book 2018: Health information for international travel","author":"Centers for Disease Control and Prevention CDC","year":"2017"},{"key":"10.1016\/j.vaccine.2025.126758_bb0075","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/14760584.2015.1083430","article-title":"Current status and future prospects of yellow Fever vaccines","volume":"14","author":"Beck","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.126758_bb0080","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1084\/jem.20072290","article-title":"Yellow fever and max Theiler: the only Nobel prize for a virus vaccine","volume":"204","author":"Norrby","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2025.126758_bb0085","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4161\/hv.28117","article-title":"The yellow fever 17D virus as a platform for new live attenuated vaccines","volume":"10","author":"Bonaldo","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.126758_bb0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11908-017-0566-9","article-title":"Live attenuated yellow Fever 17D vaccine: a legacy vaccine still controlling outbreaks in modern day","volume":"19","author":"Collins","year":"2017","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.vaccine.2025.126758_bb0095","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1473-3099(23)00131-7","article-title":"Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial","volume":"23","author":"Juan-Giner","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126758_bb0100","doi-asserted-by":"crossref","first-page":"taad037","DOI":"10.1093\/jtm\/taad037","article-title":"Enhanced safety surveillance of STAMARIL\u00ae yellow fever vaccine provided under the expanded access investigational new drug program in the USA","volume":"30","author":"Rojas","year":"2023","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2025.126758_bb0115","series-title":"Public Health Innovation [Internet]","article-title":"Yellow Fever. In: Bio-Manguinhos\/Fiocruz","author":"Christ","year":"2024"},{"key":"10.1016\/j.vaccine.2025.126758_bb0120","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/ph14090891","article-title":"The present and future of yellow Fever vaccines","volume":"14","author":"Hansen","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.vaccine.2025.126758_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0043-1768993","article-title":"Enabling real-world data to accelerate the development of innovative Cancer biomarkers","volume":"10","author":"Yeh","year":"2023","journal-title":"Global Med Genetics"},{"key":"10.1016\/j.vaccine.2025.126758_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-022-01768-6","article-title":"Real-world data: a brief review of the methods, applications, challenges and opportunities","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.vaccine.2025.126758_bb0135","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s13300-023-01458-6","article-title":"The role of real-world evidence in treatment decision-making, regulatory assessment, and understanding the perspectives of people with type 2 diabetes: examples with Gliclazide MR","volume":"14","author":"Khunti","year":"2023","journal-title":"Diabetes Therapy"},{"key":"10.1016\/j.vaccine.2025.126758_bb0140","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1097\/MLR.0b013e3181de9e17","article-title":"Prediction modeling using EHR data: challenges, strategies, and a comparison of machine learning approaches","volume":"48","author":"Wu","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2025.126758_bb0145","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/pds.4932","article-title":"Trial designs using real-world data: the changing landscape of the regulatory approval process","volume":"29","author":"Andre","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2025.126758_bb0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12869","article-title":"Feasibility of using real-world data to replicate clinical trial evidence","volume":"2","author":"Bartlett","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.126758_bb0155","author":"Health Insurance Portability and Accountability Act of 1996"},{"key":"10.1016\/j.vaccine.2025.126758_bb0160","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.vaccine.2021.12.047","article-title":"Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: a retrospective cohort study using three healthcare databases","volume":"40","author":"Ledlie","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126758_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024505","article-title":"Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow Fever","volume":"6","author":"Sch\u00e4fer","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.126758_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-229558","article-title":"Yellow fever vaccine-associated neurological disease: it is not just the silver generation at risk","volume":"12","author":"Goldstein","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.vaccine.2025.126758_bb0180","author":"CDC"},{"key":"10.1016\/j.vaccine.2025.126758_bb0185","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1016\/j.vaccine.2014.08.051","volume":"32","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T18:04:51Z","timestamp":1743876291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":29,"alternative-id":["S0264410X25000556"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126758","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world evidence of yellow Fever vaccination data-driven study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126758"}}